Categories: News

Revel + NovuHealth Become Icario

Nation’s leading health action company reveals new brand reflecting the company’s mission to connect people to health

MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) — Revel + NovuHealth today announced the launch of its new name and brand, Icario (“ih-car-ee-oh”). The new brand represents the combined business of two market leaders that merged in October 2020. Icario creates value by uniting pioneering technology, data science and behavioral insights to make the world a healthier place, one person at a time. Icario’s technology and services currently support more than 50 leading healthcare payers, including seven of the ten largest health plans in the United States.

“We chose the Icario name and brand to represent a successful, growing business that deeply understands people and is focused on making healthcare more human through personalized communication,” said Steve Wigginton, CEO of Icario. “Bringing Revel and NovuHealth together under one brand has allowed us to accelerate new product development to solve healthcare problems quickly in a highly interconnected way. There has never been a more important time to improve people’s health, and the Icario team is driven to achieve the highest health outcomes on behalf of our customers through an ever-expanding suite of capabilities.”

Icario currently helps more than 10 million health plan members per month take health actions that drive better outcomes. Icario’s expanded data analytics, adaptive multi-channel platform, and behavioral insights allow health plan customers to connect with their members in a highly personalized way. Icario’s deep expertise in Medicare and Medicaid — supporting critical quality, satisfaction and outcome measures that drive plan performance — enables the company to partner with innovative health plans and risk-bearing entities to accelerate innovation and growth.

Check out the new Icario website and brand design here: www.icariohealth.com.

About Icario
Icario is the leading health action company focused on connecting people to health. Icario uses pioneering behavioral research, data science and our adaptive multi-channel platform to deliver personalization at scale for the most trusted healthcare organizations in all 50 states, including seven of the 10 largest health plans. Learn more at www.icariohealth.com.

Media Contact:
Sandi Scott
sscott@tunheim.com 
(651) 208-4582

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

21 minutes ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

3 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

3 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

3 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

3 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

3 hours ago